Triple
T1143373
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | European Centre for Disease Prevention and Control |
E23505
|
entity |
| Predicate | focusesOn |
P31
|
FINISHED |
| Object | COVID-19 |
E67147
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: COVID-19 | Statement: [European Centre for Disease Prevention and Control, focusesOn, COVID-19]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: COVID-19 Context triple: [European Centre for Disease Prevention and Control, focusesOn, COVID-19]
-
A.
COVID-19 pandemic
chosen
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
B.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
-
C.
COVID-19 vaccines
COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
-
D.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
E.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a493ef399c8190b04b9146d2314f59 |
completed | March 1, 2026, 7:30 p.m. |
| NER | Named-entity recognition | batch_69a4bc4e93d48190b9fea886bf61aad7 |
completed | March 1, 2026, 10:23 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac59b2395c81909d4608bdaf1d57e8 |
completed | March 7, 2026, 5 p.m. |
Created at: March 1, 2026, 7:44 p.m.